According to Teresa Puig, director of the Oncology Unit of the Group for the Investigation of New Therapeutic Targets, the University of Girona has managed to isolate stem cells from one of the most aggressive breast cancers through an additive manufacturing system. A tumor is made up of many types of cells, and these are the cells we have in low proportions. Therefore, it is complicated to locate these cells within the tumor. This new system is cleaner, allowing us to work more directly with these types of cells later.
the cancer being researched is the triple-negative subtype, which occurs in young women and leads to relapses within three or four years in 20 or 30 percent of patients.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.